Editor's commentary: COPD therapies, MRSA pneumonia and New Horizons Symposium.
D003226:Congresses as Topic; D006801:Humans; D008171:Lung Diseases / Q000534:rehabilitation; D055624:Methicillin-Resistant Staphylococcus aureus; D018410:Pneumonia, Bacterial / Q000382:microbiology*; D011023:Pneumonia, Staphylococcal; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy*; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation